This site is intended for U.S. healthcare professionals.
Help protect your eligible patients with a next-generation pneumococcal conjugate vaccine1*
Prevnar 20 delivers the most serotypes in a pneumococcal conjugate vaccine by adding 7 serotypes to Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein])1,2
Both Prevnar 20 and Prevnar 13 will only help protect against Streptococcus pneumoniae serotypes in their respective vaccines.1,2
Prevnar 20 helps protect your patients against more serotypes than any other
pneumococcal conjugate vaccine. The serotypes in Prevnar 20 are associated with manifestations of pneumococcal disease like1,5-8:
Certain serotypes of Streptococcus pneumoniae included in Prevnar 20 are associated with outbreaks, antibiotic resistance, and high mortality/fatality rates.9-16
One dose of Prevnar 20 alone can help protect your eligible adult patients.1,3
Prevnar 20 contains serotypes associated with a majority of invasive pneumococcal disease.1,3
Prevnar 20 contains serotypes associated with many cases of community-acquired pneumonia.1,4
To report an adverse event, please call 1-800-438-1985
Pfizer for Professionals 1-800-505-4426
This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.
© 2023 Pfizer Inc. All rights reserved.